Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Betadek is a specialized nutritional supplement developed and marketed by Waterley Pharmaceuticals in India, primarily designed for patients with chronic liver disease and other conditions leading to micronutrient deficiencies. The product is a combination of fat-soluble vitamins—including Vitamin A (retinol and beta-carotene), Vitamin D3 (cholecalciferol), Vitamin E, and Vitamin K—along with the essential mineral zinc. This formulation is specifically intended to replenish essential vitamins and minerals that are often malabsorbed or depleted in hepatological conditions. By restoring these micronutrients, Betadek supports immune function, bone health through enhanced calcium absorption, vision, skin health, and wound healing, while also helping to manage stress and fatigue associated with chronic illness. It is approved and marketed in India as an oral tablet.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Betadek.